FERRIPROX Tablets are an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes.
How to use:
25 mg/kg to 33 mg/kg actual body weight, orally, three times per day, for a total daily dose of 75 mg/kg to 99 mg/kg body weight.
Caution & Warnings:
Liver Enzyme Elevations: Monitor monthly and discontinue for persistent elevations.
Zinc Deficiency: Monitor during therapy and supplement for deficiency.
Empyo-Fetal Toxicity: Can cause fetal harm.
Side Effects:
Nausea, vomiting, abdominal pain, arthralgia, ALT increased and neutropenia.
FERRIPROX Tablets are an iron chelator indicated for the treatment of transfusional iron overload in adult and pediatric patients 8 years of age and older with thalassemia syndromes.
How to use:
25 mg/kg to 33 mg/kg actual body weight, orally, three times per day, for a total daily dose of 75 mg/kg to 99 mg/kg body weight.
Caution & Warnings:
Liver Enzyme Elevations: Monitor monthly and discontinue for persistent elevations.
Zinc Deficiency: Monitor during therapy and supplement for deficiency.
Empyo-Fetal Toxicity: Can cause fetal harm.
Side Effects:
Nausea, vomiting, abdominal pain, arthralgia, ALT increased and neutropenia.